Literature DB >> 14693234

Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ?

Michele D Mignogna1, Stefano Fedele, Lucio Lo Russo, Lorenzo Lo Muzio, Eduardo Bucci.   

Abstract

The association of chronic inflammation with a variety of epithelial malignancies has been recognised for centuries. Well established examples include, among many others, oesophageal adenocarcinoma associated with chronic oesophagitis and bowel cancer associated with chronic inflammatory bowel diseases. By now no data, other than clinical observation, have been available in understanding the pathogenesis of these inflammation-related tumours. However, recent molecular studies on the relationship between solid malignancies and the surrounding stroma have given new insights. There is now enough evidence to accept that the chronic inflammatory process per se is able to provide a cytokine-based microenvironment which is able to influence cell survival, growth, proliferation, differentiation and movement, hence contributing to cancer initiation, progression, invasion and metastasis. Here it is discussed whether also oral lichen planus (OLP), being a chronic inflammatory autoimmune disease which has been clinically associated with development of oral squamous cell carcinoma, might be categorised among these disorders. With this aim, we critically reviewed and detailed the presence, in OLP subepithelial infiltrate, of inflammatory cells and cytokine networks that might act to promote squamous tumorigenesis.

Entities:  

Mesh:

Year:  2004        PMID: 14693234     DOI: 10.1016/j.oraloncology.2003.08.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  57 in total

1.  The dynamics of oral lichen planus: a retrospective clinicopathological study.

Authors:  Ilana Kaplan; Yael Ventura-Sharabi; Gavriel Gal; Shlomo Calderon; Yakir Anavi
Journal:  Head Neck Pathol       Date:  2011-12-13

2.  Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.

Authors:  K Völp; M-L Brezniceanu; S Bösser; T Brabletz; T Kirchner; D Göttel; S Joos; M Zörnig
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

3.  Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer.

Authors:  Yi Liu; Diana V Messadi; Hongkun Wu; Shen Hu
Journal:  Med Hypotheses       Date:  2010-07-31       Impact factor: 1.538

Review 4.  How I treat refractory chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Adela R Cardones; Keith M Sullivan
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

5.  Role of inflammation in oral carcinogenesis (Part I): Histological grading of malignancy using a binary system.

Authors:  Marta Rabello Piva; Lélia Batista DE Souza; Paulo Ricardo Saquete Martins-Filho; Rosilene Calazans Soares; Thiago DE Santana Santos; Emanuel Sávio DE Souza Andrade
Journal:  Oncol Lett       Date:  2011-08-16       Impact factor: 2.967

6.  Quantitative Evaluation of Tumour--Associated Tissue Eosinophilia and Cyclo-oxegenase-2 Gene in Oral Cancer Patients with Assessment of Long Term Outcomes.

Authors:  N Rakesh; Asha Iyengar; Kuhu Majumdar; G S Vidya; S S Shantha Kumar
Journal:  Pathol Oncol Res       Date:  2015-11-17       Impact factor: 3.201

7.  Hydroxychloroquine decreases the upregulated frequencies of Tregs in patients with oral lichen planus.

Authors:  Yanan Zhu; Jingjing Li; Yang Bai; Xiang Wang; Ning Duan; Hongliu Jiang; Tingting Wang; Wenmei Wang
Journal:  Clin Oral Investig       Date:  2014-01-14       Impact factor: 3.573

Review 8.  The role of infectious agents in the etiology of ocular adnexal neoplasia.

Authors:  Varun Verma; Defen Shen; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 6.048

Review 9.  Diagnostic aids in the screening of oral cancer.

Authors:  Stefano Fedele
Journal:  Head Neck Oncol       Date:  2009-01-30

10.  Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer.

Authors:  Hye Won Chung; Sang-Guk Lee; Heejung Kim; Duck Jin Hong; Jae Bock Chung; David Stroncek; Jong-Baeck Lim
Journal:  J Transl Med       Date:  2009-05-28       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.